Emerging trends in the synthesis and improvement of hapten-specific recombinant antibodies.
A key requirement for successful immunotherapeutic and immunodiagnostic applications is the availability of antibodies with high affinity and specificity. In the past, polyclonal antibodies from hyperimmunized animals or monoclonal antibodies from hybridoma cell lines were used extensively and profitably in medicine and immunotechnology. Antibody-based diagnostics, such as immunoassays, are also widely accepted because of their high sensitivity and ease of use as compared to conventional chromatographic techniques. While immunoassays have been used to monitor organic chemical contaminants such as pesticides, food preservatives, antibiotics in agricultural and food industries, hapten-specific antibodies with the desired affinity and specificity are generally difficult to obtain. With the advent of recombinant DNA technology, antibody genes can be amplified and selected through phage display, cell surface display, or cell-free display systems. A particularly useful feature common to all these display systems is the linking of the phenotype and genotype of antibodies during selection. This allows easy co-selection of the desired antibodies and their encoding genes based on the binding characteristics of the displayed antibodies. The selected antibody DNA can be further manipulated for high-level expression, post-translation modification, and/or affinity and specificity improvement to suit their particular applications. Several hapten-specific antibodies, which were successfully selected and engineered to high specificity and affinity using display technologies, have been found to be amenable to conventional immunoassay development. In this review, we will examine different formats of immunoassays designed for hapten identification and various display technologies available for antibody selection and improvement.
D000906:Antibodies / Q000235:genetics / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000378:metabolism; D000918:Antibody Specificity; D001709:Biotechnology / Q000639:trends*; D006241:Haptens / Q000276:immunology*; D007118:Immunoassay / Q000379:methods*; D019151:Peptide Library; D011994:Recombinant Proteins / Q000378:metabolism
D000906:Antibodies; D000911:Antibodies, Monoclonal; D006241:Haptens; D019151:Peptide Library; D011994:Recombinant Proteins